Global Cell Culture Market, Projected to Reach $48.63 Billion by 2029


Posted December 6, 2024 by Meticulous2222

Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), End User (Pharma, academic)
 
Meticulous Research®, a leading authority in market research, has announced the release of its comprehensive report titled, Cell Culture Market by Product (Consumables, Equipment), Application (Bioproduction, Cancer Research, Stem Cell Research, Diagnostics), End User (Pharmaceuticals, Academia) - Global Forecast to 2029.

Download Free Sample PDF Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=4788?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=06-12-2024

According to this detailed analysis, the global cell culture market is poised for robust growth, anticipated to expand at a compound annual growth rate (CAGR) of 11.7% during the forecast period of 2022 to 2029, ultimately reaching a staggering $48.63 billion. This growth is primarily driven by a surge in the biopharmaceutical sector, rising prevalence of chronic diseases, increased demand for monoclonal antibodies, and escalating research funding. Additionally, the growing adoption of single-use technologies is significantly contributing to the market's expansion.

Market Dynamics and Opportunities

The report highlights the increasing popularity of 3D cell culture techniques and personalized medicine as critical avenues for growth, offering substantial opportunities for market players to innovate and expand their product offerings.

Impact of COVID-19 on Cell Culture Research

The COVID-19 pandemic has notably influenced cell culture-based research activities. Understanding the dynamics of infectious viruses became imperative for effective infection control strategies. As researchers delved into the biology of various virus variants, in vitro cell culture models emerged as invaluable tools for drug efficacy testing and vaccine development.

The Centers for Disease Control and Prevention (CDC) played a pivotal role by distributing the SARS-CoV-2 virus strain, enabling researchers worldwide to employ it in their studies. Various in vitro models, including human lung epithelium, bronchial epithelial cells, and specialized extracellular matrices, were crucial for projects focused on antiviral research, vaccine efficacy, and pathogenesis.

Comprehensive Market Segmentation

The report segments the cell culture market into key categories:

By Product: Consumables (including media, reagents, sera, cell lines) and Equipment (bioreactors, centrifuges, cell counters). In 2022, the consumables segment accounted for the largest market share due to the frequent need for consumables across various applications.
By Application: The market is divided into bioproduction, drug screening & development, cancer research, and stem cell research. The bioproduction segment is projected to dominate, driven by the high demand for biopharmaceutical products.
By End User: The market includes pharmaceutical and biotechnology companies, academic and research institutions. The pharmaceutical and biotechnology segment is expected to lead, supported by a growing number of startups and increased research activities.
Regional Insights

The research evaluates key geographical markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is estimated to maintain its dominance in the cell culture market, bolstered by a robust healthcare infrastructure, advanced technological adoption, and a high prevalence of non-communicable diseases.

Leading Players in the Cell Culture Market

The report identifies major players in the cell culture market, including:

Merck KGaA (Germany)
Thermo Fisher Scientific Inc. (U.S.)
Cytiva (U.S.)
Lonza Group Ltd. (Switzerland)
Corning Incorporated (U.S.)
Becton, Dickinson and Company (U.S.)
Avantor, Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
HiMedia Laboratories (India)
Sartorius AG (Germany)
Eppendorf SE (Germany)
FUJIFILM Holdings Corporation (Japan)
Agilent Technologies, Inc. (U.S.)
Getinge AB (Sweden)
Greiner Bio-One GmbH (Austria)
Miltenyi Biotec B.V. & Co. KG (Germany)


Quick Buy @ https://www.meticulousresearch.com/Checkout/94004198?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=06-12-2024

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Dipali
Country India
Categories Business
Tags cell culture market cell culture 3d cell culture cell culture media cell culture reagents cell suspension culture cell culture techniques
Last Updated December 6, 2024